Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Medulloblastoma 3 Brain Neoplasms 2 Teratoma 1 Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Intracranial Germ Cell Tumors 1 Infratentorial Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 16 Etoposide 14 Carboplatin 11 Temozolomide 10 Vincristine 9 Granulocyte Colony-Stimulating Factor 9 Filgrastim 9 Magnetic Resonance Spectroscopy 8 Cisplatin 8 etoposide phosphate 7 X-Rays 7 Thiotepa 7 Phantoms, Imaging 7 Methotrexate 7 tazemetostat 6 Topotecan 6 Specimen Handling 6 Radiotherapy 6 Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 fludarabine 4 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Melphalan 4 Biopsy 4 palbociclib 3 Sirolimus 3 Nivolumab 3 Leucovorin 3 Irinotecan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdoid Tumor × Craniospinal Irradiation × Clear all

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡